Skip to Main Content

Author Details

Alberto Bosque
George Washington University
2000
80
30
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36798291Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.bioRxiv2023
37860759AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected <i>in vivo</i>.iScience2023
37744358Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1.Front Immunol2023
37581929The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells.JCI Insight2023
37766318IL-15 and N-803 for HIV Cure Approaches.Viruses2023
37063856Deep characterization of human γδ T cell subsets defines shared and lineage-specific traits.Front Immunol2023
36736722Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency.Ann Allergy Asthma Immunol2023
34985656The Cultured T<sub>CM</sub> Model of HIV Latency.Methods Mol Biol2022
35412343Pharmacological Targeting of Sphingosine Kinases Impedes HIV-1 Infection of CD4 T Cells through SAMHD1 Modulation.J Virol2022
36734362PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent.Nanomedicine (Lond)2022
35867565The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.J Virol2022
35985993SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8<sup>+</sup> T-cells.Nat Commun2022
33441346The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an <i>In Vitro</i> Primary T<sub>CM</sub> Cell Model of Latency.J Virol2021
34880361An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes.Sci Rep2021
34934153Publisher Correction: An ultrasensitive planar array p24 Gag ELISA to detect HIV-1 in diverse biological matrixes.Sci Rep2021
34715067Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence.Biochem Pharmacol2021
34046367Editorial: Immunotherapies Towards HIV Cure.Front Cell Infect Microbiol2021
33980597Selective BCL-X<sub>L</sub> Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from <i>Ex Vivo</i> Reservoirs.J Virol2021
34194436Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS.Front Immunol2021
33045840Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control.AIDS Res Hum Retroviruses2021
32482680Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents.Antimicrob Agents Chemother2020
34079616PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function.Nano Res2020
32027622BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.J Clin Invest2020
33086748Interferon-Mediated Long Non-Coding RNA Response in Macrophages in the Context of HIV.Int J Mol Sci2020
32790802Fingolimod inhibits multiple stages of the HIV-1 life cycle.PLoS Pathog2020
30299483Sex Influences SAMHD1 Activity and Susceptibility to Human Immunodeficiency Virus-1 in Primary Human Macrophages.J Infect Dis2019
31710657Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal.PLoS One2019
31681325Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists.Front Immunol2019
31795223HIV-1 Latency and Latency Reversal: Does Subtype Matter?Viruses2019
29764952SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition.mBio2018
29926732Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.AIDS Res Hum Retroviruses2018
30282829Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.JCI Insight2018
29355843Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells.J Clin Invest2018
28931091T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.PLoS Pathog2017
28487480Microbiota promotes systemic T-cell survival through suppression of an apoptotic factor.Proc Natl Acad Sci U S A2017
28147284Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation.Cell Rep2017
28949981Mycobacterium tuberculosis reactivates latent HIV-1 in T cells in vitro.PLoS One2017
26171776Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus.AIDS Res Hum Retroviruses2016
27898737Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.PLoS Pathog2016
27998278Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo.Retrovirology2016
26912621HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay.J Virol2016
27086912Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein.Oncotarget2016
25618414Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr.Virology2015
26355217BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.Cell Host Microbe2015
26169416Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.Antimicrob Agents Chemother2015
26215564HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.Retrovirology2015
24155393Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.J Virol2014
25310595Sulfonation pathway inhibitors block reactivation of latent HIV-1.Virology2014
25142072Replication competent virus as an important source of bias in HIV latency models utilizing single round viral constructs.Retrovirology2014
24910430Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells.Cell Rep2014
  • 1 - 50 of 80

Recommended Authors

Xiaoyu Luo
Gladstone Institutes, University of California san francisco
Career Start Year 2014
Number of shared co-authors 2
Louise E Hogan
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 5
Daniele C Cary
University of California san francisco
Career Start Year 2011
Number of shared co-authors 0
Jocelyn T Kim
University of California Los Angeles
Career Start Year 2011
Number of shared co-authors 3
Andrea Gramatica
Gladstone Institute of Virology, Gladstone Institutes
Career Start Year 2011
Number of shared co-authors 5
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
Anjana Yadav
University of Pennsylvania Perelman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
George B Kyei
Noguchi Memorial Institute for Medical Research, University of Ghana
Career Start Year 2004
Number of shared co-authors 1
Nadia R Roan
University of California, USA Gladstone Institutes san francisco
Career Start Year 2003
Number of shared co-authors 4
Timothy J Henrich
University of California san francisco
Career Start Year 2002
Number of shared co-authors 7
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 1
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 1
Gilad Doitsh
University of California san francisco
Career Start Year 1998
Number of shared co-authors 2
Stephen A Migueles
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 4
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 3
Melanie Ott
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 9
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 0
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 4
Steven G Deeks
University of California san francisco
Career Start Year 1988
Number of shared co-authors 10
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 5
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 6
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 3
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 6
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 6
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 9
Judy Lieberman
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 5
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 8
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 5
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 5

Collaborators

Vicente Planelles
University of Utah
Co-authored papers 36
Ana Beatriz DePaula-Silva
University of Utah School of Medicine
Co-authored papers 5
Robert F Siliciano
Johns Hopkins University School of Medicine
Co-authored papers 4
Eric Verdin
Buck Institute for Research on Aging
Co-authored papers 3
Paul Zumbo
Co-authored papers 3
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 2
Joseph J Eron
Co-authored papers 2
Frederic D Bushman
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
John A T Young
Roche Pharma
Co-authored papers 2
Bruce D Walker
Ragon Institute of Mass General
Co-authored papers 2
Rajesh T Gandhi
Co-authored papers 2
Peter W Ramirez
California State University Long Beach
Co-authored papers 2
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Cathal Mahon
Denali Therapeutics Inc.
Co-authored papers 1
John Marlett
Salk Institute for Biological Studies
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Ben D MacArthur
Co-authored papers 1
Patrick A Cassiday
University of Utah School of Medicine
Co-authored papers 1
Oliver Hofmann
University of Melbourne
Co-authored papers 1
Nirav Malani
University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Carlos M R Monteiro-Filho
University of Utah School of Medicine
Co-authored papers 1
Lara Manganaro
National Institute of Molecular Genetics, "Fondazione Romeo ed Enrica Invernizzi"
Co-authored papers 1
Nels C Elde
University of Utah School of Medicine
Co-authored papers 1
Jonathan Chan
From the Gladstone Institute of Virology and Immunology
Co-authored papers 1
Douglas D Richman
Center for AIDS Research, University of California San Diego
Co-authored papers 1
Shannan J Ho Sui
Harvard T.H. Chan School of Public Health
Co-authored papers 1
Joshua C Anderson
University of Alabama at Birmingham
Co-authored papers 1
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Jeffrey Chumley
University of Utah School of Medicine
Co-authored papers 1
Warner C Greene
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 1
Release 1.2